Basic & Clinical Medicine ›› 2017, Vol. 37 ›› Issue (6): 884-888.

Previous Articles     Next Articles

Research progress of capecitabine combined chemotherapy with biweekly scheme

  

  • Received:2016-05-03 Revised:2016-07-01 Online:2017-06-05 Published:2017-05-26
  • Contact: Shoudong Ma E-mail:tsmsd@sina.com

Abstract: As an oral chemotherapy drug, capecitabine is safe, effective and easy to use, has been widely used in esophageal cancer, gastric cancer, colorectal cancer, breast cancer, ovarian cancer and other solid tumor. The chemotherapy scheme mainly for 3 weeks, each cycle of capecitabine for 14 days, and 7 days off. As a modification to conventional chemotherapy, the biweekly scheme with capecitabine showed low toxicity and well tolerated by patients, short hospitalization time and other characteristics, it is worth of application in clinical.

Key words: capecitabine, chemotherapy, biweekly scheme

CLC Number: